BACKGROUND: Vibrio cholerae causes over 2 million cases of cholera and 90,000 deaths each year.
In the recent 2014-2016 Ebola epidemic in West Africa, non-hospitalized cases were an important component of the chain of transmission.
OBJECTIVE: Case-based surveillance of bacterial meningitis in sentinel districts has been recommended after the introduction of the conjugated vaccine against Neisseria meningitidis serogroup A (NmA), MenAfriVac, in the African meningi
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season.
Efficacy of Treatment as Prevention Strategy depends on a variety of factors including individuals' likelihood to test and initiate treatment, viral load and sexual behaviour.
The seventh cholera pandemic has heavily affected Africa, although the origin and continental spread of the disease remain undefined.
BACKGROUND: Early diagnosis of suspected malaria cases with a rapid diagnostic test (RDT) has been shown to be an effective malaria control tool used in many resource-constrained settings.
Growing data suggest that antimicrobial-resistant bacterial infections are common in low- and middle-income countries.
Background: In 2015, more than 1 million refugees arrived in Europe.
